Lee Hyun Jung, Cheon Jae Hee
Department of Internal Medicine and Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Korea.
Intest Res. 2017 Jul;15(3):311-317. doi: 10.5217/ir.2017.15.3.311. Epub 2017 Jun 12.
Intestinal Behçet's disease (BD), generally accepted as a type of inflammatory bowel disease (IBD), could be diagnosed when patients with BD have objectively documented gastrointestinal symptoms and intestinal ulcerations. Similar to IBD, intestinal BD has an unpredictable disease course with relapse and remission and is often related to a poor prognosis. However, there is no single gold standard for assessment of the disease activity of intestinal BD, and its diagnosis and management depend heavily on expert opinions. The Korean IBD Study Group recently developed novel diagnostic criteria based on colonoscopy findings and clinical manifestations using a modified Delphi process to overcome drawbacks of previously used consensus for the diagnosis of intestinal BD. In addition, the recently developed disease activity index for intestinal BD, consisting of a relatively simple 8-point index, could also help in determining treatment strategies and monitoring therapeutic responses. In this review, the progress in the diagnosis and disease activity measurement of intestinal BD will be discussed.
肠道白塞病(BD)通常被认为是一种炎症性肠病(IBD),当BD患者出现客观记录的胃肠道症状和肠道溃疡时即可诊断。与IBD相似,肠道BD的病程不可预测,有复发和缓解,且常与预后不良有关。然而,目前尚无评估肠道BD疾病活动度的单一金标准,其诊断和管理很大程度上依赖专家意见。韩国IBD研究组最近基于结肠镜检查结果和临床表现,采用改良德尔菲法制定了新的诊断标准,以克服先前用于诊断肠道BD的共识的缺点。此外,最近开发的肠道BD疾病活动指数由一个相对简单的8分指数组成,也有助于确定治疗策略和监测治疗反应。在这篇综述中,将讨论肠道BD诊断和疾病活动度测量方面的进展。